← Evidence map

TrialBlood cancer journal2022

The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation.

Ruth Meier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35995769